Researchers determined the prevalence of neuropsychiatric systemic lupus erythematosus in patients with psychosis with positive antinuclear antibodies.
Researchers conducted a systematic review and meta-analysis to assess the incidence and predictors of psychosis relapse in individuals receiving treatment with antipsychotic agents.
Compared with usual treatment, the use of long-acting injectable antipsychotics significantly increased the time to first hospitalization in patients with early-phase schizophrenia.
Patients with schizophrenia and a history of catatonia had greater deficits in the cognitive domains of immediate memory, verbal fluency, and processing speed compared to patients with schizophrenia alone.
In this Q&A, Dr Rupak Desai discusses the overlap between adult congenital heart disease and mental health disorders.
A growing body of research suggests there may be associations between common viral infectious such as Epstein Barr and Toxoplasma gondii and schizophrenia.
Augmentation with guanfacine alongside cognitive remediation and social skills may be an effective intervention for patients with schizotypal personality disorder.
Emerging evidence has begun to elucidate the prevalence and outcomes associated with social anxiety disorder in schizophrenia.
Examination of raw data does not show a multi-modal distribution of immune parameter data in patients.
Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.
